Latest News and Press Releases
Want to stay updated on the latest news?
-
Promising results from the SAMURAI study show NeuroAiDTMII significantly improves post-concussion symptoms, QoL and mood post-mild traumatic brain injury.
-
Investigator-initiated clinical trial of SLT (CognivAiDTM) for mild cognitive impairment (MCI) reported significant improvement in key cognitive domains.